Zobrazeno 1 - 10
of 14
pro vyhledávání: '"J. Chad Williamson"'
Autor:
Timothy J. Atkinson, Christopher Gharibo, Barbara J Martin, Leanne Berger, Thomas Sullivan, Bill H. McCarberg, Charles Argoff, J. Chad Williamson
Publikováno v:
Journal of Pain Research
Chad Williamson,1 Barbara J Martin,2 Charles Argoff,3 Christopher Gharibo,4 Bill McCarberg,5 Timothy Atkinson,6 Leanne Berger,1 Thomas Sullivan1 1Rockpointe, Columbia, MD, USA; 2Independent Consultant Physician/Writer, Lancaster, PA, USA; 3Albany Med
Autor:
B. Stephen Burton, Terry Ann Glauser, Daxa Patel, Anne Marie Dubois, J. Chad Williamson, Doron Schneider
Publikováno v:
Postgraduate Medicine. 126:145-160
To identify attitudes and practices of endocrinologists (ENDOs), family practitioners (FPs), internists (IMs), primary care nurse practitioners (NPs), physician assistants (PAs), certified diabetes educators (CDEs), retail pharmacists (R-PHs), and ho
Publikováno v:
Journal of Cancer Education. 28:591-596
The Lymphoma Research Foundation offers Grand Rounds continuing medical education (CME) activities on specific issues related to advances in the management of patients with lymphoma. The 2012 activity comprised interactive case studies presented by l
Autor:
J. Chad Williamson, Davida F. Kruger, Anne Marie Dubois, P. Holder Nevins, Suzanne F. Whitfield, B. Scott Urquhart, Terry Ann Glauser, Doron Schneider
Publikováno v:
Clinical Diabetes. 31:3-9
IN BRIEF This article describes the results of surveys distributed to a national audience of specialty, primary care, and allied health care providers (HCPs) who manage patients with type 2 diabetes on a daily basis. The results provide insights into
Autor:
Patti Merwin, Terry Ann Glauser, Mary M. Sugrue, B. Stephen Burton, J. Chad Williamson, Elizabeth M. Sagatys, Christine Berger, John M. Bennett
Publikováno v:
Leukemia research. 37(12)
Myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic stem cell malignancies that represent a diagnostic challenge for pathologists. Accurate classification and prognostic scoring are essential to treating MDS. To understand fact
Publikováno v:
B44. LUNG CANCER: ADVANCES IN IMAGING, BIOMARKERS, SCREENING, AND TREATMENT.
Publikováno v:
Clinical Communications-Oncology. 1:6
Background: The management of patients with nonsmall cell lung carcinoma (NSCLC) is evolving rapidly. There have been Food and Drug Administration approvals for new therapies or expanded use of existing therapies in each of the last 6-year, with thre
Publikováno v:
Clinical Communications-Oncology. 1:5
The available options for treating prostate cancer (PC) have increased dramatically in recent years with new chemical, hormonal, and immunological treatment receiving Food and Drug Administration approval since 2008. We conducted a longitudinal study
Autor:
Elizabeth M. Sagatys, B. Stephen Burton, Patti Merwin, J. Chad Williamson, Mary M. Sugrue, Christine Berger, Terry Ann Glauser
Publikováno v:
Blood. 120:4242-4242
Abstract 4242 MDS are a heterogeneous group of hematopoietic stem cell disorders whose incidence appears to be increasing. Establishing the diagnosis of MDS requires careful morphologic review of the peripheral blood, bone marrow (BM) aspirate and bi
Publikováno v:
American Journal of Clinical Pathology. 138:A157-A157
This study was conducted to measure current perceptions, knowledge level, and practice patterns of pathologists in using biomarkers in lung, breast, and gastric cancer management. A survey was developed to elicit information from practicing US pathol